Kathleen R. Mulka

A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

Linglei Jiang, Tom A. P. Driedonks, Wouter S. P. Jong et al. · Journal of Extracellular Vesicles · 2022 · 150 citations · Full text

Vaccination, Extracellular Vesicles, Mucosal Vaccination +14

Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer

Arlene L. Oei, Preethi Korangath, Kathleen R. Mulka et al. · International Journal of Hyperthermia · 2019 · 58 citations · Full text

Androgen receptor signaling in the lungs mitigates inflammation and improves the outcome of influenza in mice

Landon G. vom Steeg, Santosh Dhakal, Yishak A. Woldetsadik et al. · PLoS Pathogens · 2020 · 49 citations · Full text

Asthma, Androgen Receptor, Inflammatory Lung Disease +17

Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters

Kathleen R. Mulka, Sarah E. Beck, Clarisse V. Solis et al. · American Journal Of Pathology · 2021 · 30 citations · Full text

Respiratory Diseases, Medicine, Covid-19 Pandemic +5

A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants

Linglei Jiang, Tom A. P. Driedonks, Wouter S.P. Jong et al. · 2021 · 24 citations · Full text